Model-Based Dosing Optimization of Teicoplanin in Critically Ill Patients
S. KANG (Seoul, Republic of Korea), H. Jo (Seoul, Republic of Korea), E. Chung (Seoul, Republic of Korea), S. Rhie (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea)
Source: International Congress 2022 – Pneumonia
Session: Pneumonia
Session type: Thematic Poster
Number: 4035
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. KANG (Seoul, Republic of Korea), H. Jo (Seoul, Republic of Korea), E. Chung (Seoul, Republic of Korea), S. Rhie (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea). Model-Based Dosing Optimization of Teicoplanin in Critically Ill Patients. 4035
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|